Radiochemotherapy in Stage III/IV Head and Neck Cancer
Author Information
Author(s): Schäfer C, Dietl B, Kölbl O
Primary Institution: Department of Radiooncology, University of Regensburg Hospital
Conclusion
The study suggests that combined radiochemotherapy may lead to inferior outcomes compared to adjuvant radiotherapy, despite not reaching statistical significance.
Supporting Evidence
- The authors noted a higher rate of grade 3 toxicity with radiochemotherapy compared to adjuvant radiotherapy.
- The study's low accrual rate was identified as a major problem.
- Quality of life parameters were not included in the study.
Takeaway
The study looked at two treatments for head and neck cancer and found that one might not be better than the other, but the results were not clear.
Potential Biases
The study design may have biased results by selecting patients who preferred surgery over radiochemotherapy.
Limitations
The trial was prematurely stopped due to low patient enrollment, and the sample size was small, which may affect the reliability of the results.
Participant Demographics
Patients with resectable head and neck cancer.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website